Risk Factors and Outcomes Associated With Posttransplant Diabetes Mellitus in Kidney Transplant Recipients

被引:37
|
作者
Siraj, E. S. [1 ,2 ]
Abacan, C. [1 ]
Chinnappa, P. [1 ]
Wojtowicz, J. [1 ]
Braun, W. [2 ,3 ]
机构
[1] Cleveland Clin, Dept Diabet Endocrinol & Metab, Cleveland, OH 44106 USA
[2] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Hypertens & Nephrol, Cleveland, OH 44106 USA
关键词
INTERNATIONAL CONSENSUS GUIDELINES; RENAL-ALLOGRAFT RECIPIENTS; ISCHEMIC-HEART-DISEASE; INSULIN-RESISTANCE; CYCLOSPORINE; IMPACT; HYPERGLYCEMIA; MANAGEMENT; PROGNOSIS;
D O I
10.1016/j.transproceed.2009.12.062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although our understanding of the risk factors involved in the occurrence of posttransplant diabetes mellitus (PTDM) as well as its outcomes has improved, it still remains incomplete. Our study attempts to analyze the risk factors as well as the outcomes associated with PTDM in the renal transplant patients at the Cleveland Clinic. Methods. Our study is a retrospective, case-control study. We screened 209 charts of 217 patients who received single-organ kidney transplant at the Cleveland Clinic between January 1996 and December 1998. PTDM was defined by the American Diabetes Association criteria of either a fasting blood glucose >= 126 mg/dL or random blood sugars mg/dL confirmed on a second occasion. Kidney transplant recipients who developed PTDM (cases) were compared with kidney transplant recipients who did not develop diabetes but were matched for the time of transplant (controls). Results. Forty-nine patients (23%) developed PTDM. The data of 47 cases and 47 controls were analyzed. Age >= 40 years, body mass index >= 30, pretransplant triglyceride levels >150 mg/dL, and presence of graft rejection were significant risk factors for developing PTDM. Smoking was associated with increased risk of PTDM but failed to achieve statistical significance. Compared with controls, PTDM patients had higher risk of cardiovascular disease, infections, and graft rejection. Conclusion. Our results show that PTDM is a significant problem after kidney transplantation, and those who have high risk should be closely monitored after transplant and aggressively treated if they develop diabetes to minimize the risk of complications.
引用
收藏
页码:1685 / 1689
页数:5
相关论文
共 50 条
  • [41] Posttransplant diabetes mellitus: Incidence and risk factors
    Mazali, F. Cr.
    Lalli, Cr. A.
    Alves-Filho, G.
    Mazzali, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (03) : 764 - 766
  • [42] Risk factors and incidence of posttransplant diabetes mellitus
    Reisæter, AV
    Hartmann, A
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (5A) : 8S - 18S
  • [43] Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
    Halden, Thea Anine Strom
    Kvitne, Kine Eide
    Midtvedt, Karsten
    Rajakumar, Laavanyaah
    Robertsen, Ida
    Brox, Jan
    Bollerslev, Jens
    Hartmann, Anders
    Asberg, Anders
    Jenssen, Trond
    [J]. DIABETES CARE, 2019, 42 (06) : 1067 - 1074
  • [44] Bacteremia in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes
    Brar, S.
    Wang, Y.
    Cannitelli, A.
    Li, Y.
    Famure, O.
    Husain, S.
    Kim, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 471 - 472
  • [45] NEUTROPENIA IN KIDNEY AND LIVER TRANSPLANT RECIPIENTS: RISK FACTORS AND OUTCOMES
    Mavrakanas, T.
    Fournier, M. A.
    Clairoux, S.
    Amiel, J. A.
    Tremblay, M. E.
    Vinh, D. C.
    Coursol, C.
    Thirion, D. J. G.
    Cantarovich, M.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 176 - 177
  • [46] Neutropenia in kidney and liver transplant recipients: Risk factors and outcomes
    Mavrakanas, Thomas A.
    Fournier, Marie-Andree
    Clairoux, Sarah
    Amiel, Jacques-Alexandre
    Tremblay, Marie-Eve
    Vinh, Donald C.
    Coursol, Christian
    Thirion, Daniel J. G.
    Cantarovich, Marcelo
    [J]. CLINICAL TRANSPLANTATION, 2017, 31 (10)
  • [47] Pre-transplant Hyperparathyroidism and Adverse Posttransplant Outcomes in Kidney Transplant Recipients
    Rodrigues, Fernanda
    van der Plas, Willemijn
    Sotomayor, Camilo
    van der Vaart, Amarens
    Daan, Kremer
    Navis, Gerjan
    Bakker, Stephan J. L.
    de Borst, Martin H.
    [J]. TRANSPLANTATION, 2022, 106 (09) : S405 - S405
  • [48] Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients
    Axelrod, David A.
    Cheungpasitporn, Wisit
    Bunnapradist, Suphamai
    Schnitzler, Mark A.
    Xiao, Huiling
    McAdams-DeMarco, Mara
    Caliskan, Yasar
    Bae, Sunjae
    Ahn, JiYoon B.
    Segev, Dorry L.
    Lam, Ngan N.
    Hess, Gregory P.
    Lentine, Krista L.
    [J]. KIDNEY MEDICINE, 2022, 4 (01)
  • [49] CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept
    Karadkhele, Geeta
    Hogan, Julien
    Magua, Wairimu
    Zhang, Weiwen
    Badell, Idelberto Raul
    Mehta, Aneesh
    Lyon, Marshall
    Pastan, Stephen
    Pearson, Thomas C.
    Larsen, Christian P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (01) : 208 - 221
  • [50] Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors
    Ollech, Jacob E.
    Kramer, Mordechai R.
    Peled, Nir
    Ollech, Ayelet
    Amital, Anat
    Medalion, Benjamin
    Saute, Milton
    Shitrit, David
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (05) : 844 - 848